Patent ID: 11964057
Assignee: RJH BIOSCIENCES INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 28:
29. A method of treating, preventing, or ameliorating blood cancer in a subject, comprising administering to the subject an effective amount of a compound having the formula (I):, , wherein x, y and z are repeating units in polyethylenimine, and x is 7 to 22 repeating units, y is 14 to 44 repeating units, and z is 1 to 5 repeating units;, and wherein the compound is capable of delivering a ribonucleic acid; a nanoparticle comprising the compound complexed to a ribonucleic acid, or a composition comprising the compound or the nanoparticle and a pharmaceutically acceptable carrier, a targeting ligand, an anti-fouling agent, or combination thereof.